Literature DB >> 6203881

Evidence for the separate molecular expression of four distinct polymorphic Ia epitopes on cells of DR4 homozygous individuals.

T Toguchi, G Burmester, A Nunez-Roldan, P Gregersen, S Seremetis, S Lee, I Szer, R Winchester.   

Abstract

The monoclonal antibodies 109d6 and IVD12 reacted with separate polymorphic Ia epitopes in immunofluorescent studies. Using a panel of lymphoblastoid B cell lines, antibody 109d6 reacted with all HLA-DR4 or DR7 positive lines in a pattern resembling the MT3 specificity recognized by human alloantisera. The antibody IVD12 reacted with all HLA-DR4 and two of three DR5 positive B cell lines suggesting that it recognized a specificity similar to MB3. The intensity of fluorescence was greater on DR5(+) cell lines than on DR4(+) cell lines relative to the amount of a nonpolymorphic Ia determinant. Among 45 unrelated control individuals reactivity with antibody 109d6 was correlated most closely with (r = 0.724) but not identical in occurrence to the MT3 specificity. Cocapping experiments demonstrated that the 109d6 epitope and the IVD12 epitope were present on independently redistributed cell surface molecules of DR4 homozygous lymphoblastoid cell lines. Furthermore, the DR4 alloantigens detected by an absorbed polyclonal human alloserum were similarly identified on molecules that were independent from those bearing either the 109d6 epitope or the IVD12 epitope. Taken together, these data indicate the existence of at least four distinct, serologically defined Ia molecular species.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6203881     DOI: 10.1016/0198-8859(84)90074-0

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.211


  10 in total

1.  Differential expression of Ia antigens by rheumatoid synovial lining cells.

Authors:  G R Burmester; B Jahn; P Rohwer; J Zacher; R J Winchester; J R Kalden
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

2.  Structural organization of the DR subregion of the human major histocompatibility complex.

Authors:  T Spies; R Sorrentino; J M Boss; K Okada; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

3.  Strong association of rheumatoid arthritis with the presence of a polymorphic Ia epitope defined by a monoclonal antibody: comparison with the allodeterminant DR4.

Authors:  S H Lee; P K Gregersen; H H Shen; A Nunez-Roldan; J Silver; R J Winchester
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

4.  Human T cells recognize mycobacterial heat shock proteins in the context of multiple HLA-DR molecules: studies with healthy subjects vaccinated with Mycobacterium bovis BCG and Mycobacterium leprae.

Authors:  A S Mustafa; K E Lundin; F Oftung
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

5.  Definition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of a polymorphic Ia epitope.

Authors:  S Seremetis; J Cuttner; R Winchester
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

6.  Definition of AML susceptibility and classification using monoclonal antibodies.

Authors:  S Seremetis; J Cuttner; R Winchester
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

7.  An HLA-DRw53-restricted T-cell epitope from a novel Mycobacterium leprae protein antigen important to the human memory T-cell repertoire against M. leprae.

Authors:  A S Mustafa; A Deggerdal; K E Lundin; R M Meloen; T M Shinnick; F Oftung
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

Review 8.  [80 milestones in rheumatology from 80 years- III. 1980-2000].

Authors:  Gerd-Rüdiger Burmester; Joachim R Kalden; Thomas Rose
Journal:  Z Rheumatol       Date:  2021-07-08       Impact factor: 1.372

9.  Identification, at the genomic level, of an HLA-DR restriction element for cloned antigen-specific T4 cells.

Authors:  G Paulsen; E Qvigstad; G Gaudernack; L Rask; R Winchester; E Thorsby
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

10.  Molecular localization of human class II MT2 and MT3 determinants.

Authors:  C K Hurley; R C Giles; G Nunez; R DeMars; L Nadler; R Winchester; P Stastny; J D Capra
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 17.579

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.